Furthermore, TREM2 can also play a protective role in HCC by inhibiting toll-like receptor 4 (TLR4)-induced inflammatory responses (62, 63), reducing activated proteins downstream of TLR4 (such as p38-MAPK and ERK) to reduce inflammation levels and suppress chronic inflammation (60). The gene discussed is TLR4; the disease is hepatocellular carcinoma.